Jean-Philippe Fortin Selected Research

B-9958

4/2006

Discovery of a dual-function peptide that combines aminopeptidase N inhibition and kinin B1 receptor antagonism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Philippe Fortin Research Topics

Disease

5	Inflammation (Inflammations) 02/2020 - 12/2004
4	Neoplasms (Cancer) 11/2020 - 09/2009
3	Obesity 01/2019 - 01/2014
3	Tics (Tic) 02/2008 - 09/2005
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2011
2	Hypersensitivity (Allergy) 08/2015 - 11/2010
2	Pain (Aches) 04/2006 - 12/2004
1	Insulin Resistance 01/2023
1	Virus Diseases (Viral Diseases) 01/2021
1	Infections 02/2020
1	Hereditary Angioedemas 02/2020
1	Edema (Dropsy) 02/2020
1	Weight Loss (Weight Reduction) 01/2015
1	Rickets (Rachitis) 04/2013
1	Experimental Liver Neoplasms 09/2009
1	Fibrosarcoma 09/2009
1	Lung Neoplasms (Lung Cancer) 02/2008
1	Prostatic Neoplasms (Prostate Cancer) 02/2008
1	Sepsis (Septicemia) 12/2004

Drug/Important Bio-Agent (IBA)

6	Peptides (Polypeptides)IBA 02/2020 - 09/2005
4	KininsIBA 11/2010 - 12/2004
3	Proteins (Proteins, Gene)FDA Link 02/2020 - 09/2009
3	lysyllysine (Lys-Lys)IBA 02/2008 - 09/2005
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2011
2	CytokinesIBA 02/2020 - 11/2010
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2013 - 12/2004
2	amastatinIBA 04/2006 - 09/2005
1	NucleotidesIBA 01/2021
1	Type C PhospholipasesIBA 02/2020
1	icatibantIBA 02/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019
1	Deoxyribonucleases (DNase)FDA Link 08/2015
1	hydrogen sulfite (bisulfite)IBA 08/2015
1	Drug CombinationsIBA 01/2015
1	Peptide Hormones (Polypeptide Hormones)IBA 10/2014
1	Transcription Factors (Transcription Factor)IBA 01/2014
1	bursiconIBA 04/2013
1	Cystine (L-Cystine)IBA 04/2013
1	Drosophila G proteinIBA 04/2013
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2011
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2010
1	Inflammation MediatorsIBA 11/2010
1	Factor VIIa (Activated Factor VII)IBA 09/2009
1	Thromboplastin (Tissue Factor)IBA 09/2009
1	Green Fluorescent ProteinsIBA 09/2009
1	1,2,3,4-tetrahydroisoquinolineIBA 02/2008
1	Hydroxyproline (4 Hydroxyproline)IBA 02/2008
1	Carboxylic AcidsIBA 02/2008
1	AcidsIBA 02/2008
1	B10324IBA 02/2008
1	B-9958IBA 04/2006
1	CD13 Antigens (Alanine Aminopeptidase)IBA 04/2006
1	BradykininIBA 04/2006
1	Chromogenic CompoundsIBA 04/2006
1	Arginine (L-Arginine)FDA Link 04/2006
1	2,5-dichloro-4-bromophenol (B 2)IBA 01/2006

Therapy/Procedure

2	Therapeutics 01/2015 - 01/2014
1	Immunotherapy 11/2020
1	Precision Medicine 01/2015
1	Drug Therapy (Chemotherapy) 10/2014